DreaMed Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

DreaMed General Information

Description

Developer of a diabetes management system designed to optimize intensive insulin therapy. The company's system uses event-driven machine learning and logic technology to process multiple personalized parameters such as insulin delivery data, glucose readings, meal data, and optimized insulin dosing treatment plans, enabling care providers and patients to improve living standards and lower overall treatment costs.

Contact Information

Website
www.dreamed.ai
Formerly Known As
Advisor Pro
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • P.O. Box 3271
  • Petah Tikva 4952701
  • Israel
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • P.O. Box 3271
  • Petah Tikva 4952701
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DreaMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Later Stage VC 19-Aug-2024 Completed Generating Revenue
6. Mezzanine 15-Feb-2022 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Early Stage VC 18-Sep-2017 Completed Generating Revenue
3. Early Stage VC (Series A) 25-Jul-2016 Completed Generating Revenue
2. Grant 03-Feb-2016 $3.4M $2M Completed Generating Revenue
1. Angel (individual) 06-Apr-2015 $2M $2M Completed Generating Revenue
To view DreaMed’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

DreaMed Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a diabetes management system designed to optimize intensive insulin therapy. The company's system uses even
Monitoring Equipment
Petah Tikva, Israel
30 As of 2026

San Diego, CA
 

Malvern, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DreaMed Competitors (15)

One of DreaMed’s 15 competitors is GlySens, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlySens Venture Capital-Backed San Diego, CA
LifeScan Formerly PE-Backed Malvern, PA
GlucoTrack Technologies Corporate Backed or Acquired Rutherford, NJ
DexCom Formerly VC-backed San Diego, CA
Ascensia Diabetes Care Formerly PE-Backed Basel, Switzerland
You’re viewing 5 of 15 competitors. Get the full list »

DreaMed Patents

DreaMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4430626-A1 Method and system for automatic monitoring of diabetes related treatments based on insulin injections Pending 12-Nov-2020
US-20250014707-A1 Method and system for automatic monitoring of diabetes related treatments based on insulin injections Pending 12-Nov-2020
WO-2022101900-A1 Method and system for automatic monitoring of diabetes related treatments based on insulin injections Inactive 12-Nov-2020
US-20210193285-A1 A system and method for use in disease treatment management Inactive 19-Oct-2017
WO-2019077482-A1 A system and method for use in disease treatment management Inactive 19-Oct-2017 G16H20/17
To view DreaMed’s complete patent history, request access »

DreaMed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DreaMed Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
eHealth Ventures (Israel) Venture Capital Minority
A-Labs Corporation Minority
OurCrowd Venture Capital Minority
StartUp Health Venture Capital Minority
Medtronic Corporation Minority
You’re viewing 5 of 7 investors. Get the full list »

DreaMed FAQs

  • When was DreaMed founded?

    DreaMed was founded in 2014.

  • Where is DreaMed headquartered?

    DreaMed is headquartered in Petah Tikva, Israel.

  • What is the size of DreaMed?

    DreaMed has 30 total employees.

  • What industry is DreaMed in?

    DreaMed’s primary industry is Monitoring Equipment.

  • Is DreaMed a private or public company?

    DreaMed is a Private company.

  • What is DreaMed’s current revenue?

    The current revenue for DreaMed is .

  • How much funding has DreaMed raised over time?

    DreaMed has raised $9.5M.

  • Who are DreaMed’s investors?

    eHealth Ventures (Israel), A-Labs, OurCrowd, StartUp Health, and Medtronic are 5 of 7 investors who have invested in DreaMed.

  • Who are DreaMed’s competitors?

    GlySens, LifeScan, GlucoTrack Technologies, DexCom, and Ascensia Diabetes Care are some of the 15 competitors of DreaMed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process